Qulipta
Atogepant
- Clinical contraindication
- None listed
- No clinical contraindication identified.
- Best available evidence
- Standard practice
- Half-life
- Not recorded
Clinical data and state rules are separate facts. Both are shown; neither is a decision.
No known interaction; not serotonergic or vasoconstrictive. Nausea, constipation.
No reported interaction is not a finding of safety: most combinations with psilocybin have never been studied. Whether this combination suits a particular person is for their prescriber and provider to decide.
No pharmacology properties of concern are listed for this record.
No provision names this medication or its class.
Colorado · checked 2026-09-30No provision names this medication or its class.
Oregon · checked 2026-09-30New Mexico's clinical rules (proposed 7.35.3 NMAC) are not final. No provision naming this medication has been found.
New Mexico · checked 2026-09-30No condition named in state rules is linked to this medication.